BioVectra Inc
$46,472,500.00 CAD
- Program
- SIF Stream2- Growth
- Recipient country
- Canada
- Fiscal year
- 2021-2022
- Agreement period
- November 1, 2021 – December 31, 2023
- Reference
- ic:033-2021-2022-Q4-816245
Published purpose
This project will provide vital vaccines and therapies to Canadians by constructing a state-of-the-art biomanufacturing facility to close an existing gap in domestic production. The project will increase mRNA and pDNA vaccine production as well as establish capabilities to fill-and-finish vaccines.
In plain English AI-generated
Funding to BioVectra Inc. to build a biomanufacturing facility in Canada that will increase domestic production of mRNA and pDNA vaccines and establish fill-and-finish capabilities, supporting vital vaccines and therapies for Canadians.
Category: Health Primarily funds activity in Canada
Based on the published description. See how AI categorization works — the linked official record is authoritative.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.